{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.58","meta":{"versionId":"3","lastUpdated":"2015-07-14T01:00:00.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.58","version":"20150714","name":"Trastuzumab Administration","status":"active","date":"2015-07-14T01:00:00-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","concept":[{"code":"327397006","display":"Trastuzumab (product)"},{"code":"327399009","display":"Trastuzumab 150mg powder for infusion solution vial (product)"},{"code":"375356000","display":"Trastuzumab 440mg powder for injection solution vial (product)"},{"code":"387003001","display":"Trastuzumab (substance)"},{"code":"702836004","display":"Trastuzumab emtansine (substance)"}]}]}}